Coeptis Therapeutics Holdings Inc reported III. Quarter net loss per share of $-0.06 compare to earnings per share of $0.45 in the same quarter a year ago a decrease compare to $-0.03 realized in previous quarter.
III. Quarter
Earnings Per Share
Revenues
$ -0.06
$
0 Mill
$-0.51
Unch.
Coeptis Therapeutics Holdings Inc 's Revenue
fell by
0 % in III. Quarter (Sep 30 2022) year on year,
to $0 million and
declined by
sequentially.
Coeptis Therapeutics Holdings Inc is Expected to report next financial results on November 17, 2023.
Coeptis Therapeutics Holdings Inc 's
in III. Quarter recorded net loss of $-0.305 million, compare to net income of $4.177 million achieved in III. Quarter a year ago.
